Product
PBP1502
1 clinical trial
1 indication
Indication
Healthy Control ParticipantsClinical trial
A Phase 1, Double-blind, Randomized, Three-arm, Parallel Group Study to Compare the Pharmacokinetics and Safety of a Single Subcutaneous Dose of PBP1502, EU-Humira®, and US-Humira® in Healthy Male and Female Subjects.Status: Recruiting, Estimated PCD: 2024-11-01